Gambia vs Italy: The number of people with susceptibility test result for rifampicin
Gambia
1,175
in 2021
Italy
1,391
in 2021
Gambia rank
62nd
Italy rank
60th
The number of people with susceptibility test result for rifampicin over time
- Gambia
- Italy
How they compare
Italy currently reports 1,391 against 1,175 in Gambia, a difference of 216.
That makes Italy's figure about 1.2 times Gambia's.
Across all 5 years both countries report, Italy has been ahead every year.
Gambia ranks 62nd and Italy ranks 60th of 155 countries.
Italy has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Gambia | Italy | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1 | 1,785 | 1,784 | Italy |
| 2020s | 646 | 1,278 | 632 | Italy |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Gambia or Italy?
- Italy, at 1,391 against 1,175 in Gambia as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Gambia and Italy?
- 216, with Italy ahead.
- How many years of comparable data are there for Gambia and Italy?
- 5 years are reported by both, from 2017 to 2021.
- How do Gambia and Italy rank globally for the number of people with susceptibility test result for rifampicin?
- Gambia ranks 62nd and Italy ranks 60th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.